MERCK, TEVA DROP TRIAL PLANS IN BONE-DRUG PATENT FIGHT

A long-scheduled showdown between Merck & Co. and Teva Pharmaceuticals USA Inc. over rights to once-weekly formulations of osteoporosis treatments has been taken off the calendar of a federal court.
Easy Bourse